| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 228.391.754 $ | +132.196.012 $ | +56,4 % | 10 | 178.831.797 $ | +93.398.552 $ | +57,1 % | 9 | 109.863.732 $ | +80.185.787 $ | +182,3 % | 6 | ||||
| Apogee Therapeutics, Inc. | APGE | → 0 | Schwach | 31.479.580 $ | +3.250.060 $ | +11,5 % | 1 | 28.229.520 $ | +16.151.600 $ | +133,7 % | 1 | ||||
| Vor Biopharma Inc. | VOR | → 0 | Neutral | 31.220.000 $ | +13.299.000 $ | +74,2 % | 1 | 17.921.000 $ | +17.921.000 $ | 1 | |||||
| Zura Bio Ltd | ZURA | → 0 | Neutral | 25.084.784 $ | +5.089.311 $ | +25,5 % | 1 | 19.995.473 $ | +3.472.496 $ | +21,0 % | 1 | 16.522.977 $ | +13.194.273 $ | +396,4 % | 1 |
| Amylyx Pharmaceuticals, Inc. | AMLX | → 0 | Neutral | 24.325.000 $ | +3.185.000 $ | +15,1 % | 1 | 21.140.000 $ | -1.963.000 $ | -8,5 % | 1 | 23.103.000 $ | +10.283.000 $ | +80,2 % | 1 |
| Rezolute, Inc. | RZLT | → 0 | Neutral | 23.047.005 $ | +9.517.764 $ | +70,3 % | 1 | ||||||||
| ImmunityBio, Inc. | IBRX | → 0 | Stark | 23.016.136 $ | +23.016.136 $ | 1 | |||||||||
| NEKTAR THERAPEUTICS | NKTR | → 0 | Neutral | 22.768.793 $ | +13.859.044 $ | +155,5 % | 1 | 17.070.000 $ | +17.070.000 $ | 1 | |||||
| Sol-Gel Technologies Ltd. | SLGL | → 0 | 21.735.037 $ | +21.735.037 $ | 1 | ||||||||||
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 19.852.500 $ | +19.852.500 $ | 1 | |||||||||
| RAPT Therapeutics, Inc. | RAPT | → 0 | 19.684.804 $ | +19.684.804 $ | 1 | ||||||||||
| Immunovant, Inc. | IMVT | → 0 | Neutral | 19.065.000 $ | +11.005.000 $ | +136,5 % | 1 | ||||||||
| ALUMIS INC. | ALMS | → 0 | Stark | 18.859.024 $ | +18.859.024 $ | 1 | |||||||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 18.520.000 $ | +3.310.000 $ | +21,8 % | 1 | 15.210.000 $ | +15.210.000 $ | 1 | ||||||
| BRIGHT MINDS BIOSCIENCES INC. | DRUG | → 0 | Schwach | 16.053.400 $ | +16.053.400 $ | 1 | |||||||||
| Ascendis Pharma A/S | ASND | → 0 | 14.910.750 $ | +14.910.750 $ | 1 | ||||||||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 14.423.500 $ | +3.964.152 $ | +37,9 % | 1 | ||||||||
| Annexon, Inc. | ANNX | → 0 | Schwach | 13.850.000 $ | +13.850.000 $ | 1 | |||||||||
| 228.391.754 $ | +132.196.012 $ | +56,4 % | 10 | 178.831.797 $ | +93.398.552 $ | +57,1 % | 9 | 109.863.732 $ | +80.185.787 $ | +182,3 % | 6 | ||||